AI & Digital Health

Why Health Apps Aren’t Enough Anymore

June 4, 2026
|
by Dr. Ebot Eyong

Your sleep data sits in one place. Your glucose trends live somewhere else. Your stress levels are isolated. Each app tells you what’s happening in its own narrow world—but your body doesn’t work that way. Health is interconnected. Poor sleep affects glucose. Stress impacts blood pressure. Mental health influences weight. When these signals are disconnected, you’re left guessing.

Most people today use multiple health apps—one for sleep, another for glucose, and another for stress. On the surface, it feels like you’re in control. You’re tracking everything.

But here’s the problem: none of these apps talk to each other.

Your sleep data sits in one place. Your glucose trends live somewhere else. Your stress levels are isolated. Each app tells you what’s happening in its own narrow world—but your body doesn't work that way.

Health is interconnected.

Poor sleep affects glucose. Stress impacts blood pressure. Mental health influences weight. When these signals are disconnected, you’re left guessing.

That’s why tracking alone isn't enough anymore.

The future of health isn't about collecting more data. It’s about connecting it.

This is where a new category is emerging: Health Intelligence Infrastructure.

Instead of separate tools, imagine a system that brings everything together—analyzing patterns across sleep, glucose, stress, and more. A system that doesn’t just show numbers but explains relationships.

This is the shift from data trackingdatatracking to data understanding.

Platforms like eeMeds are built around this idea. Not as another app, but as a data brain that connects your health signals into one unified picture.

Because real health insight doesn't come from isolated metrics.

It comes from seeing how everything works together.

Explore More Publications

Continue exploring Dr. Ebot Eyong’s professional insights on healthcare regulation, FDA submissions, AI-enabled medical devices, quality systems, and global compliance strategy.

EU Regulatory Strategy

EU Proposal to Revise MDR and IVDR: Implications for Innovation, Documentation, and Software Oversight

February 17, 2026
|
By Dr. Ebot Eyong

The European Commission has proposed a targeted revision of the Medical Device Regulation and In Vitro Diagnostic Regulation aimed at supporting innovation while reducing unnecessary administrative burden. This article explores the impact on technical documentation, manufacturers, implementation challenges, and software oversight.

Read Article

CMC & FDA Submissions

Top 10 Premarket Authorization Challenges for Medical Device Manufacturers Navigating Regulatory Complexity from Concept to Market Approval

July 9, 2026
|
By Dr. Eyong Ebot

Discover the top 10 premarket authorization challenges facing medical device manufacturers and learn practical strategies to accelerate FDA 510(k), De Novo, and PMA approvals.

Read Article

Real-World Evidence

FDA Update on Real-World Evidence: Implications for AI-Enabled Medical Devices

May 2, 2025
|
By Dr. Ebot Eyong

The U.S. Food and Drug Administration has updated its Real-World Evidence policies to allow greater use of large, well-curated data sources in medical device marketing submissions. This article explains how RWE may support safety and effectiveness for AI-enabled medical devices.

Read Article

CMC & FDA Submissions

FDA Guidance for Chemistry, Manufacturing, and Controls (CMC) Submissions

January 15, 2025
|
By Dr. Ebot Eyong

The FDA provides several guidance documents for Chemistry, Manufacturing, and Controls submissions, including post-approval manufacturing changes, comparability protocols, disposable manufacturing materials, nanomaterials, and current good manufacturing practice requirements for combination products.

Read Article